| Paramyxovirus fusion and entry: multiple paths to a common end A Chang, RE Dutch Viruses 4 (4), 613-636, 2012 | 244 | 2012 |
| Viral entry mechanisms: the increasing diversity of paramyxovirus entry EC Smith, A Popa, A Chang, C Masante, RE Dutch The FEBS journal 276 (24), 7217-7227, 2009 | 217 | 2009 |
| Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate A Chang, C Masante, UJ Buchholz, RE Dutch Journal of virology 86 (6), 3230-3243, 2012 | 118 | 2012 |
| Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry RM Schowalter, A Chang, JG Robach, UJ Buchholz, RE Dutch Journal of virology 83 (3), 1511-1522, 2009 | 96 | 2009 |
| The human metapneumovirus small hydrophobic protein has properties consistent with those of a viroporin and can modulate viral fusogenic activity C Masante, F El Najjar, A Chang, A Jones, CL Moncman, RE Dutch Journal of virology 88 (11), 6423-6433, 2014 | 51 | 2014 |
| Determinants of neutralizing antibody response after SARS CoV-2 vaccination in patients with myeloma AK Nooka, U Shanmugasundaram, N Cheedarla, H Verkerke, VV Edara, ... Journal of Clinical Oncology 40 (26), 3057, 2022 | 37 | 2022 |
| Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphoma S Merdan, K Subramanian, T Ayer, J Van Weyenbergh, A Chang, JL Koff, ... Blood cancer journal 11 (1), 2, 2021 | 36 | 2021 |
| Humoral responses against SARS-CoV-2 and variants of concern after mRNA vaccines in patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia A Chang, A Akhtar, SL Linderman, L Lai, VM Orellana-Noia, ... Journal of Clinical Oncology 40 (26), 3020, 2022 | 34 | 2022 |
| Paramyxovirus fusion and entry: multiple paths to a common end. Viruses 4: 613–636 A Chang, RE Dutch | 28 | 2012 |
| Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma RA Harkins, A Chang, SP Patel, MJ Lee, JS Goldstein, S Merdan, ... Expert review of hematology 12 (11), 959-973, 2019 | 23 | 2019 |
| Potential electrostatic interactions in multiple regions affect human metapneumovirus F-mediated membrane fusion A Chang, BA Hackett, CC Winter, UJ Buchholz, RE Dutch Journal of virology 86 (18), 9843-9853, 2012 | 23 | 2012 |
| Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients CL Dean, CL Maier, S Chonat, A Chang, MA Carden, F El Rassi, ... Transfusion 59 (5), 1698-1705, 2019 | 22 | 2019 |
| Antibody response to COVID-19 mRNA vaccine in patients with lung cancer after primary immunization and booster: reactivity to the SARS-CoV-2 WT virus and Omicron variant RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, ... Journal of Clinical Oncology 40 (33), 3808, 2022 | 21 | 2022 |
| Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: reactivity to vaccine antigen and variants of concern RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, ... MedRxiv, 2022.01. 03.22268599, 2022 | 15 | 2022 |
| Influenza vaccination rates among patients with a history of cancer: analysis of the National health interview survey A Chang, MK Ellingson, CR Flowers, RA Bednarczyk Open Forum Infectious Diseases 8 (7), ofab198, 2021 | 11 | 2021 |
| Human metapneumovirus fusion protein triggering: Increasing complexities by analysis of new HMPV fusion proteins JT Kinder, EM Klimyte, A Chang, JV Williams, RE Dutch Virology 531, 248-254, 2019 | 9 | 2019 |
| Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies A Chang, JL Koff, L Lai, VM Orellana-Noia, M Surati, AMK Leal, ML Ellis, ... Blood advances 7 (11), 2459-2462, 2023 | 8 | 2023 |
| Myocarditis with radiotherapy and immunotherapy in multiple myeloma A Chang, TH Nasti, MK Khan, S Parashar, JL Kaufman, LH Boise, ... Journal of oncology practice 14 (9), 561-564, 2018 | 7 | 2018 |
| Influenza vaccination documentation rates during the first year after diagnosis of diffuse large B cell lymphoma A Chang, JB Payne, PB Allen, JL Koff, R Ahmed, CR Flowers, ... Clinical Lymphoma Myeloma and Leukemia 19 (4), 239-243, 2019 | 6 | 2019 |
| Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome A Chang, D Schlafer, CR Flowers, PB Allen Expert opinion on investigational drugs 27 (1), 55-70, 2018 | 6 | 2018 |
